Literature DB >> 17713696

[Kleptomania: clinical characteristics and treatment].

Jon E Grant1, Brian L Odlaug.   

Abstract

OBJECTIVES: Kleptomania, a disabling impulse control disorder, is characterized by the repetitive and uncontrollable theft of items that are of little use to the afflicted person. Despite its relatively long history, kleptomania remains poorly understood to the general public, clinicians, and sufferers.
METHOD: This article reviews the literature for what is known about the clinical characteristics, family history, neurobiology, and treatment options for individuals with kleptomania.
RESULTS: Kleptomania generally has its onset in late adolescence or early adulthood and appears to be more common among women. Lifetime psychiatric comorbidity is frequent, mainly with other impulse control (20-46%), substance use (23-50%) and mood disorders (45-100%). Individuals with kleptomania suffer significant impairment in their ability to function socially and occupationally. Kleptomania may respond to cognitive behavioral therapy and various pharmacotherapies (lithium, anti-epileptics, and opioid antagonists).
CONCLUSIONS: Kleptomania is a disabling disorder that results in intense shame, as well as legal, social, family, and occupational problems. Large scale treatment studies are needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713696     DOI: 10.1590/s1516-44462006005000054

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  2 in total

1.  A case of venlafaxine-induced kleptomania.

Authors:  Benedetta Demartini; Armando D'Agostino; Clara Basi; Orsola Gambini
Journal:  Eur J Clin Pharmacol       Date:  2015-12-26       Impact factor: 2.953

Review 2.  Pathological gambling: a review of the neurobiological evidence relevant for its classification as an addictive disorder.

Authors:  Mira Fauth-Bühler; Karl Mann; Marc N Potenza
Journal:  Addict Biol       Date:  2016-03-03       Impact factor: 4.280

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.